Vasily Vlassov

Publications¹⁴⁵

• Article Plis S. S., Veselkina O. V., Klevno V. A., Vlassov V. Acute lethal poisonings in children: a 10-year retrospective study of the Moscow Region, Russia // Journal of Public Health Research. 2022. Vol. 11. No. 1. Article 1932. doi
• Article Peden A. E., Cullen P., Moeller H., Francis K. L., V Vlassov, S S Otstavnov. Adolescent Transport and Unintentional Injuries: A Systematic Analysis Using the Global Burden of Disease Study 2019 // The Lancet Public Health. 2022. Vol. 7. No. 8. P. E657-E669. doi
• Article Kocarnik J. M., Compton K., Dean F. E., Weijia F., Otstavnov S., Vlassov V. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019 // JAMA Oncology. 2022. Vol. 8. No. 3. P. 420-444. doi
• Article Khabibullina A., Aleksandrova E., Gerry C., Vlassov V. First population norms for the EQ-5D-3L in the Russian Federation // Plos One. 2022. Vol. 17. No. 3. Article e0263816. doi
• Article GBD 2019 Ageing C., Vlassov V. Global, Regional, and National Burden of Diseases and Injuries for Adults 70 Years and Older: Systematic Analysis for the Global Burden of Disease 2019 Study // The BMJ. 2022. Vol. 376. Article e068208. doi
• Article Haakenstad A., Irvine C. M., Knight M., Bintz C., Otstavnov S., Vlassov V. Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 // The Lancet. 2022. Vol. 399. No. 10341. P. 2129-2154. doi
• Article Plis S. S., Veselkina O. V., Klevno V. A., Vlassov V. Mortality in Cases of Acute Alcohol Intoxication in Children: A 10-Year Retrospective Study of the Moscow Region, Russia // American Journal of Forensic Medicine and Pathology. 2022. Vol. 43. No. 3. P. 231-235. doi
• Article Shishkin S., Vlassov V., Sheiman I., Potapchik E., Sazhina S. V. Structural changes in the Russian health care system: do they match European trends? // Health Economics Review. 2022. Vol. 12. Article 29. doi
• Article Haagsma J. A., Charalampous P., Ariani F., Gallay A., Vlassov V. The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study // Archives of Public Health. 2022. Vol. 80. No. 1. Article 142. doi
• Article GBD 2019 Adolescent Young Adult Cancer C., Otstavnov S., Vlassov V. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 // The Lancet Oncology. 2022. Vol. 23. No. 1. P. 27-52. doi
• Article Bucci E. M., Berkhof J., Gillibert A., Gopalakrishna G., Vlassov V. Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial // The Lancet. 2021. Vol. 397. No. 10288. P. 1881-1883. doi
• Article Azzopardi P. S., Ward J. L., Vlassov V., Otstavnov S., Francis K. L. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 // The Lancet. 2021. Vol. 398. No. 10311. P. 1593-1618. doi
• Article Paulson K. R., Kamath A. M., Alam T., Bienhoff K., Abady G. G., Vlassov V., Kassebaum N. J. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019 // The Lancet. 2021. Vol. 398. No. 10303. P. 870-905. doi
• Article GBD 2019 Hearing Loss C., Vlassov V. Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019 // The Lancet. 2021. Vol. 397. No. 10278. P. 996-1009. doi
• Article Ledovskikh Y., Vlassov V. May the Cleaning of Prescriptive Documents Using Best Evidence Reduce the Cost of Prescribed Healthcare? // Value in Health Regional Issues. 2021. Vol. 25. P. 108-111. doi
• Article GBD 2019 Dementia C., Vlassov V. The Burden of Dementia due to Down Syndrome, Parkinson’s Disease, Stroke, and Traumatic Brain Injury: A Systematic Analysis for the Global Burden of Disease Study 2019 // Neuroepidemiology. 2021. Vol. 55. No. 4. P. 286-296. doi
• Article Chaplenko A., Gildeeva G., Vlassov V. The Entry Lag of Innovative Drugs in Russia, 2010–2019 // International Journal of Environmental Research and Public Health. 2021. Vol. 18. No. 10. Article 5052. doi
• Article Micah A. E., Cogswell I. E., Cunningham B., Vlassov V., Dieleman J. L. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050 // The Lancet. 2021. Vol. 398. No. 10308. P. 1317-1343. doi
• Article Vlassov V. Use of multidimensional item response theory methods for dementia prevalence prediction: an example using the Health and Retirement Survey and the Aging, Demographics, and Memory Study // BMC Medical Informatics and Decision Making. 2021. Vol. 21. No. 1. Article 241. doi
• Article Haagsma J. A., James S. L., Castle C. D., Dingels Z. V., Vlassov V. Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017 // Injury Prevention. 2020. Vol. 26. No. Supp 1. P. i12-i26. doi
• Article James S. L., Castle C. D., Dingels Z. V., Vlassov V. Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study // Injury Prevention. 2020. Vol. 26. P. i125-i153. doi
• Article GBD 2019 Viewpoint Collaborators -., Vlassov V. Five insights from the Global Burden of Disease Study 2019 // The Lancet. 2020. Vol. 396. No. 10258. P. 1135-1159. doi
• Article GBD 2019 Demographics Collaborators .., Vlassov V. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019 // The Lancet. 2020. Vol. 396. No. 10258. P. 1160-1203. doi
• Article Vlassov V. Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: a systematic analysis for the Global Burden of Disease Study 2016 // Occupational and Environmental Medicine. 2020. Vol. 77. No. 3. P. 151-159. doi
• Article Driscoll T., Rushton L., Hutchings S. J., Vlassov V. Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016 // Occupational and Environmental Medicine. 2020. Vol. 77. No. 3. P. 133-141. doi
• Article Vos T., Lim S. S., Lim S. S., Vlassov V. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 // The Lancet. 2020. Vol. 396. No. 10258. P. 1204-1222. doi
• Article GBD 2019 Risk Factors Collaborators -., Vlassov V. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 // The Lancet. 2020. Vol. 396. No. 10258. P. 1223-1249. doi
• Article Vlassov V. Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017 // Injury Prevention. 2020. Vol. suppl 1. P. i96-i114. doi
• Article Micah A. E., Su Y., Bachmeier S. D., Vlassov V. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3 // The Lancet. 2020. Vol. 396. No. 10252. P. 693-724. doi
• Article Kinyoki D. K., Osgood-Zimmerman A. E., Pickering B. V., Vlassov V., Otstavnov S. Mapping child growth failure across low- and middle-income countries // Nature. 2020. Vol. 577. P. 231-234. doi
• Article Graetz N., Woyczynski L., Vlassov V. Mapping disparities in education across low- and middle-income countries // Nature. 2020. Vol. 577. No. 7789. P. 235-238. doi
• Article GBD 2019 Universal Health Coverage Collaborators -., Vlassov V. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 // The Lancet. 2020. Vol. 396. No. 10258. P. 1250-1284. doi
• Article Vlassov V. Quality improvement in hospitals in the Russian Federation, 2000-2016: a systematic review // Health Economics, Policy and Law. 2020. Vol. 15. No. 3. P. 403-413. doi
• Article Vlassov V., Shishkin S., Chirikova A., Vlasova A. An idea alien to both worlds: why health care rationing is not acceptable in the USA and Russia // Journal of Medical Law and Ethics. 2019. Vol. 7. No. 3. P. 231-240. doi
• Article Vlassov V. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study // JAMA Oncology. 2019. P. 1749-1768. doi
• Article Vlassov V. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a sys-tematic analysis for the Global Burden of Disease Study 2016 // The Lancet Neurology. 2019. Vol. 18. No. 1. P. 88-106. doi
• Article Vlassov V. Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016 // The BMJ. 2019. Vol. 364. P. 1-11. doi
• Article Vlassov V., Otstavnov S. Mapping 123 million neonatal, infant and child deaths between 2000 and 2017 // Nature. 2019. Vol. 574. P. 353-358. doi
• Article Vlassov V. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050 // The Lancet. 2019. Vol. 393. No. 10187. P. 2233-2260. doi
• Article Vlassov V. Russia needs to look beyond longevity // The Lancet Public Health. 2019. Vol. 4. No. 4. P. 169-170. doi
• Article Vlassov V. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 // The Lancet. 2018. Vol. 392. No. 10152. P. 1015-1035. doi
• Article Vlassov V. Global Mortality From Firearms, 1990-2016 // JAMA - Journal of the American Medical Association. 2018. Vol. 320. No. 8. P. 792-814. doi
• Article Vlassov V. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016 // New England Journal of Medicine. 2018. Vol. 379. No. 25. P. 2429-2437. doi
• Article Vlassov V. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study // JAMA Oncology. 2018. Vol. 4. No. 11. P. 1553-1568. doi
• Article Vlassov V. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 // The Lancet. 2018. Vol. 392. No. 10159. P. 1684-1735. doi
• Article Vlassov V. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 // The Lancet. 2018. Vol. 392. No. 10159. P. 1736-1788. doi
• Article Vlassov V. Global, regional, and national burden of tuberculosis, 1990-2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study // The Lancet Infectious Diseases. 2018. P. 1329-1349. doi
• Article Vlassov V. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 // The Lancet. 2018. Vol. 392. No. 10159. P. 1923-1994. doi
• Article Vlassov V. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 // The Lancet. 2018. Vol. 392. No. 10159. P. 1859-1922. doi
• Article Vlassov V. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 // The Lancet. 2018. Vol. 392. No. 10159. P. 1789-1858. doi
• 
  Book Vlassov V. Healthcare systems: Future predictions for global care. CRC Press, 2018.
• Article Vlassov V. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 // The Lancet. 2018. Vol. 391. No. 10136. P. 2236-2271. doi
• Article Vlassov V. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017 // The Lancet. 2018. Vol. 392. No. 10159. P. 2091-2138. doi
• Article Vlassov V. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 // The Lancet. 2018. Vol. 392. No. 10159. P. 1995-2051. doi
• Article Vlassov V. Russia: thirty years in transition // European Journal of Public Health. 2018. Vol. 28. No. 4. P. 588-589. doi
• Chapter Vlassov V., Swaim M. The Future of Physicians’ Specialization, in: Healthcare systems: Future predictions for global care. CRC Press, 2018. Ch. 29. P. 235-240.
• Article Vlassov V. The burden of cardiovascular diseases among US states, 1990–2016 // JAMA Cardiology. 2018. Vol. 3. No. 5. P. 375-389. doi
• Article Vlassov V. The burden of disease in Russia from 1980 to 2016: a systematic analysis for the Global Burden of Disease Study 2016 // The Lancet. 2018. Vol. 392. No. 10153. P. 1138-1146. doi
• Article Vlassov V. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015 // The Lancet Infectious Diseases. 2018. Vol. 18. No. 3. P. 261-284. doi
• Article Huang L., Zhang L., Liu Y., Luo R., Zeng L., Telegina I., Vlassov V. Arbidol for preventing and treating influenza in adults and children // Cochrane Database of Systematic Reviews. 2017 doi
• Article Vlassov V. Child and Adolescent Health From 1990 to 2015. Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study // JAMA Pediatrics. 2017. Vol. 171. No. 6. P. 573-592. doi
• Article Vlassov V. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015 // JAMA - Journal of the American Medical Association. 2017. Vol. 317. No. 2. P. 165-182. doi
• Article Vlassov V. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 // Journal of the American College of Cardiology. 2017. Vol. 70. No. 1. P. 1-25. doi
• Article Vlassov V. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study // JAMA Oncology. 2017. Vol. 3. No. 4. P. 524-548. doi
• Article Vlassov V. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 // The Lancet. 2017. Vol. 390. No. 10100. P. 1151-1210. doi
• Article Vlassov V. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 // The Lancet Neurology. 2017. Vol. 16. No. 11. P. 877-897. doi
• Article Vlassov V. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 // The Lancet. 2017. Vol. 390. No. 10100. P. 1345-1422. doi
• Article Vlassov V. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 // The Lancet Respiratory Medicine. 2017. Vol. 5. No. 9. P. 691-706. doi
• Article Vlassov V. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic anal-ysis for the Global Burden of Disease Study 2016 // The Lancet. 2017. Vol. 390. No. 10100. P. 1260-1344. doi
• Article Vlassov V. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 // The Lancet. 2017. Vol. 390. No. 10100. P. 1211-1259. doi
• Article Vlassov V. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 // The Lancet. 2017. Vol. 390. No. 10100. P. 1084-1150. doi
• Article Vlassov V. Health Effects of Overweight and Obesity in 195 Countries over 25 Years // New England Journal of Medicine. 2017. Vol. 377. No. 1. P. 13-27. doi
• Article Vlassov V. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015 // The Lancet. 2017. Vol. 390. No. 10091. P. 231-266. doi
• Article Vlassov V. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 // The Lancet. 2017. Vol. 390. No. 10100. P. 1423-1459. doi
• Article Vlassov V. Precautionary bias // European Journal of Public Health. 2017. Vol. 27. No. 3. P. 389. doi
• Article Vlassov V., Vishnevsky A. G. Privatisation and mortality in Russia // The Lancet Public Health. 2017. Vol. 2. No. 5. P. e207-e208. doi
• Chapter Vlassov V., Lindenbraten A. Russia: Progress in Healthcare Quality in Russia, in: Health Systems Improvement Across the Globe: Success Stories from 60 Countries. Boca Raton : Taylor and Francis, 2017. Ch. 31. P. 237-241.
• Article Vlassov V. Russian medicine: trying to catch up on scientific evidence and human values // The Lancet. 2017. Vol. 390. No. 10102. P. 1619-1620. doi
• Article Vlassov V. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 // The Lancet. 2017. Vol. 389. No. 10082. P. 1885-1906. doi
• Article Vlassov V. Strategies to Improve Stroke Care Services in Low- and Middle-Income Countries: A Systematic Review // Neuroepidemiology. 2017. Vol. 49. No. 1-2. P. 45-61. doi
• Article Vlassov V. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National LevelResults From the Global Burden of Disease Study 2015 // JAMA Oncology. 2017. Vol. 3. No. 12. P. 1683-1691. doi
• Article Vlassov V. Estimates of global, regional, and national incidence, prevalence and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015 // The Lancet HIV. 2016. Vol. 3. No. 8. P. e361-e387. doi
• Article Vlassov V. Global and national burden of diseases and injuries among children and adolescents between 1990 and 2013: findings from the Global Burden of Disease 2013 Study // JAMA Pediatrics. 2016. Vol. 170. No. 3. P. 267-287. doi
• Article Feigin V. L., Roth G. A., Naghavi M., Parmar P., Krishnamurthi R., Mensah G. A., Chugh S., Norrving B., Shiue I., Vlassov V. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 // The Lancet Neurology. 2016. Vol. 15. No. 9. P. 913-924. doi
• Article Vlassov V. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 // The Lancet. 2016. Vol. 388. No. 10053. P. 1603-1658. doi
• Article Vlassov V. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 // The Lancet. 2016. Vol. 388. No. 10053. P. 1545-1602. doi
• Article Vlassov V. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 // The Lancet. 2016. Vol. 388. No. 1053. P. 1775-1812. doi
• Article Vlassov V. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 // The Lancet. 2016. Vol. 388. No. 10053. P. 1459-1544. doi
• Article Vlassov V. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015 // The Lancet. 2016. Vol. 388. No. 10053. P. 1725-1774. doi
• Article Vlassov V. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 // The Lancet. 2016. Vol. 388. No. 10053. P. 1725-1774. doi
• Article Vlassov V. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 // The Lancet. 2016. Vol. 388. No. 10053. P. 1813-1850. doi
• Article Vlassov V. Protect Syria's doctors: an open letter to world leaders // The Lancet. 2016. Vol. 388. P. 1056-1056. doi
• Article Vlassov V. Russian experience and perspectives of quality assurance in healthcare through standards of care // Health Policy and Technology. 2016. Vol. 5. P. 307-403. doi
• Article Vlassov V. The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the Global Burden of Disease study 2013 // Injury Prevention. 2016. Vol. 22. No. 1. P. 3-18. doi
• Article Vlassov V.V. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 // The Lancet. 2016. Vol. 388. No. 10049. P. 1081-1088. doi
• Article Vlassov V. Atlas of the Global Burden of Stroke (1990-2013): The GBD 2013 Study // Neuroepidemiology. 2015. Vol. 45. No. 3. P. 230-236. doi
• Article Vlassov V. Global, regional and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 195 countries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 // The Lancet. 2015. Vol. 386. No. 10010. P. 2287-2323. doi
• Article Vlassov V. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 // The Lancet. 2015. Vol. 386. No. 10010. P. 2287-2323. doi
• Article Vlassov V. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and in-juries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemio-logical transition Status // The Lancet. 2015. Vol. 386. No. 10009. P. 2145-2191. doi
• Article Vlassov V. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 // The Lancet. 2015. Vol. 386. No. 9995. P. 743-800. doi
• Article Vlassov V. Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013 // Neuro-epidemiology. 2015. Vol. 45. No. 3. P. 203-214. doi
• Article Vlassov V. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study // Neuro-epidemiology. 2015. Vol. 45. No. 3. P. 190-202. doi
• Article Vlassov V. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Children and Youth Aged 0-19 Years: Data from the Global and Regional Burden of Stroke 2013 // Neuro-epidemiology. 2015. Vol. 45. No. 3. P. 177-189. doi
• Article Vlassov V. Testing treatments interactive (TTi): helping to equip the public to promote better research for better health care // Journal of Evidence-Based Medicine. 2015. Vol. 8. No. 2. P. 98-102. doi
• Article Vlassov V. The global burden of cancer 2013 // JAMA Oncology. 2015. Vol. 1. No. 4. P. 505-527.
• Article Vlassov V. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study // Neuro-epidemiology. 2015. Vol. 45. No. 3. P. 161-176. doi
• Article Vlassov V. GBD Mortality and Causes of Death Collaborators. Global, regional, and national levels of age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 // The Lancet. 2014. Vol. 385. No. 9963. P. 117-171. doi
• Article Vlassov V. Global, regional and national incidence and death for HIV, tuberculosis and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 // The Lancet. 2014. Vol. 348. No. 9947. P. 1005-1070. doi
• Article Vlassov V. Global, regional, and national levels and causes of maternal mortality during 1990—2013: a systematic analysis for the Global Burden of Disease Study 2013 // The Lancet. 2014. Vol. 384. No. 9947. P. 980-1004. doi
• Article Vlassov V. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013 // The Lancet. 2014. Vol. 384. No. 9945. P. 766-781. doi
• Article Vlassov V. Is Evidence Based Public Heath in crisis? // European Journal of Public Health. 2014. Vol. 24. No. 6. P. 873-873. doi
• Article Vlassov V., Rahu M., Pega F., Andreeva T., Ay P., Baburin A., Bencko V., Scepe P., Gebska-Kuczerowska A., Ondrusova M., Ribak J. Population health and status of epidemiology: WHO European Region I // International Journal of Epidemiology. 2013. Vol. 42. No. 3. P. 870-885.
• 
  Book Власов В. В., Плавинский С. Л. Варианты лекарственного обеспечения для России: уроки стран Европы и всего мира. М. : Медиасфера, 2013.
• Article Власов В. В. Действия врача в отношении бесперспективного больного: проблемы законодательного регулирования // Здравоохранение. 2013. № 10. С. 86-95.
• Article Власов В. В. Доступность медицинской помощи для бедных в Российской Федерации // Правовые вопросы в здравоохранении. 2013. № 7. С. 72-82.
• 
  Book Власов В. В. Общая врачебная практика: национальное руководство Т. 1. М. : ГЭОТАР-Медиа, 2013.
• 
  Book Власов В. В., Линденбратен А. Л., Комаров Ю. М. Основные положения стратегии охраны здоровья населения РФ на период 2013-2020 гг. и последующие годы. М. : Комитет гражданских инициатив, 2013.
• Article Власов В. В. Почему гастроэнтерология должна быть доказательной // Доказательная гастроэнтерология. 2013. Т. 1. № 2. С. 101-110.
• Article Власов В. В., Твигг Дж., Хассинк С., Зиглер Д., Демин А. К., Дмитриева Е. В. Прекращение потребления табака и лечение табачной зависимости // Наркология. 2013. № 9. С. 44-60.
• Article Власов В. В. Разработка и использование стандартов медицинской помощи: состояние проблемы в России и возможности улучшения качества первичной медицинской помощи. Часть 3 // Здравоохранение. 2013. № 5. С. 66-72.
• Article Власов В. В. Стандарты медицинской помощи: состояние проблемы в России и возможности улучшения качества первичной медицинской помощи - 2 // Здравоохранение. 2013. № 4. С. 70-76.
• Article Власов В. В. Стандарты медицинской помощи: состояние проблемы в России и возможности улучшения качества первичной медицинской помощи -1 // Здравоохранение. 2013. № 3. С. 76-83.
• Article Vlassov V. The enigma of Russian waves and not so bad prospects // European Journal of Public Health. 2012. Vol. 22. No. 6. P. 752-752. doi
• Article Власов В. В., Аксенов В. А. Гомеопатия: технология разведения // Здравоохранение. 2012. № 11. С. 80-87.
• Article Зиганшина Л., Власов В. В. Обязаны ли ЛПУ применять только лекарства из перечня ЖНВЛП? // Здравоохранение. 2012. № 2. С. 80-86.
• Article Власов В. В. Оценка медицинских технологий - барьер на пути нерациональных расходов в здравоохранении // Заместитель главного врача: лечебная работа и медицинская экспертиза. 2012. № 1
• Article Власов В. В., Реброва О. Оценка популяционной эффективности медицинских технологий // Медицинские технологии. Оценка и выбор. 2012. № 3. С. 33-41.
• Article Власов В. В., Седова Н. Н. Применение теории доказательств в медицине // Медицинское образование и профессиональное развитие. 2012. № 1. С. 33-42.
• Article Власов В. В., Плавинский С. Л. Статистический инструментарий для скептического читателя и медицинского исследователя // Медицинское образование и профессиональное развитие. 2012. № 1. С. 7-14.
• Article Власов В. В. GCP против Хельсинкской декларации // Казанский медицинский журнал. 2011. № 11. С. 748-752.
• Article Сошников С., Власов В. В., Граница А., Сосунов Р., Смирнов А., Владимиров С. Контент-анализ запатентованыых методов лечения наркологических расстройств в России // Неврологический вестник. Журнал им. В.М. Бехтерева. 2011. № 4. С. 3-7.
• Article Шабашов А., Саверский А., Демин А., Власов В. В. Решающая атака - правовые аспекты оборота табачной продукции // Наркология. 2011. № 5. С. 90-94.
• Article Groves T. The role of Cochrane Review authors in exposing research misconduct // The Cochrane Library. 2010. No. 8
• Article Реброва О., Власов В. В. Доказательная медицина: информационные инструменты // Заместитель главного врача: лечебная работа и медицинская экспертиза. 2010. № 3. С. 66-75.
• Article Реброва О., Власов В. В. Доказательная медицина: поиск научно обоснованной информации // Заместитель главного врача: лечебная работа и медицинская экспертиза. 2010. № 2. С. 44-53.
• Article Реброва О., Власов В. В. Доказательная медицина: формулировка актуального клинического вопроса, иерархия доказательств, источники информации // Заместитель главного врача: лечебная работа и медицинская экспертиза. 2010. № 1. С. 66-73.
• Article Власов В. В. Значение научных публикаций в специализированных журналах // Журнал неврологии и психиатрии им. С.С. Корсакова. 2010. № 7. С. 87-89.
• Article Власов В. В. Обновленные Основы: Обсуждение проекта закона "Об основах охраны здоровья граждан в Российской Федерации" // Заместитель главного врача: лечебная работа и медицинская экспертиза. 2010. № 11
• Article Реброва О., Власов В. В. Скрининг с позиций доказательной медицины: польза или вред? // Заместитель главного врача: лечебная работа и медицинская экспертиза. 2010. № 5. С. 48-59.
• Article Vlassov V., Shishkin S. Russia's healthcare system: in need of modernisation // The BMJ. 2009. No. 338
• Article Vlassov V., Jüni P., Aebersold D., Bremen K., Bekkering G., Rutjes A., Kleijnen J. The Effectiveness and Safety of Proton Radiation Therapy for Indications of the Eye: A Systematic Review. // Strahlentherapie und Onkologie. 2009. No. 185. P. 211-221.
• Article Danishevskiy K., Vlassov V. Biomedical journals and databases in Russia and Russian language in the former Soviet Union and beyond // Emerging Themes in Epidemiology. 2008. No. 5(1)
• Article Власов В. В. Изучаем и учим статистике // Международный журнал медицинской практики. 2006. № 1
• 
  Book Власов В. В. Эпидемиология / Изд-е 2-е. М. : ГЭОТАР-Медиа, 2006.
• Article Vlassov V. Health Care, Medical Practice, and Medical Ethics in Russia Today // JAMA - Journal of the American Medical Association. 1995. Vol. 273. No. 20. P. 1569-1573. doi